WASHINGTON (dpa-AFX) - Kroger Co. (KR) Monday said it has agreed to the sale
of its specialty pharmacy business to CarelonRx, a subsidiary of Elevance
Health.

Colleen Lindholz, President of Kroger Health, said, 'As part of our regular
review of assets, it became clear that our strong specialty pharmacy business
unit will better meet its full potential outside of our business. One of the
most important considerations was continued operations to ensure minimal
disruption to our associates and patients.'

The retailer's specialty pharmacy serves patients with chronic illness that
requires complex care. Skilled clinicians and superior therapy programs allow
patients and prescribers to benefit from education and resources, counseling,
side effect management, financial assistance, personalized care and
administrative expertise.

Kroger Specialty Pharmacy is separate from other Kroger Family of Pharmacies,
including in-store retail pharmacies and The Little Clinics, and therefore
in-store retail pharmacies and The Little Clinics are not included in this
transaction.

The transaction is subject to customary closing conditions, including regulatory
approvals and is expected to close in the second half of 2024. It is not
expected to have an impact on Kroger's 2024 guidance.



Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX